Gregory Simonian, MD
Vascular Surgery · Hackensack, NJNPI 1528017944
Payments from drug & device makers
Across 50 payments — averaging $182.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Octapharma USA, Inc.$6K
- W. L. Gore & Associates, Inc.$843
- Cook Medical LLC$396
- Silk Road Medical, Inc.$320
- Penumbra, Inc.$280
- Cvrx, Inc.$256
- plus $848 from 12 others
Across 1 payment — averaging $4000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$4K
What the payments were for
- Speaking & faculty fees$6,00066%
- Travel & lodging$1432%
- Food & beverage$2,99733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Octapharma USA, Inc. | 8 | $6,197 |
| W. L. Gore & Associates, Inc. | 15 | $843 |
| Cook Medical LLC | 3 | $396 |
| Silk Road Medical, Inc. | 3 | $320 |
| Penumbra, Inc. | 2 | $280 |
| Cvrx, Inc. | 1 | $256 |
| Inari Medical, Inc. | 2 | $170 |
| Medtronic | 1 | $144 |
| Boston Scientific | 2 | $107 |
| Checkpoint Surgical, Inc | 1 | $96 |
| Lemaitre Vascular, Inc. | 3 | $67 |
| Bard Peripheral Vascular, Inc. | 2 | $61 |
| Cardiva Medical, Inc. | 1 | $58 |
| Kerecis Limited | 1 | $46 |
| Angiodynamics, Inc. | 2 | $40 |
| Shockwave Medical, Inc | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BALFAXAR$6,000
- Zenith Spiral-Z$337
- ENROUTE Transcarotid Neuroprotection System$306
- Indigo System$280
- Barostim Neo System$256
- ENROUTE Transcarotid Stent$165
- SYMPLICITY G3$144
- ENROUTE Transcarotid Stent System$141
- ENHANCE Transcarotid Peripheral Access Kit$141
- ENROUTE 0.014 Guidewire$141
- FlowTriever$139
- ClotTriever$139
- GORE EXCLUDER Iliac Branch Endoprosthesis$126
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$108
How this compares
$9,140 in reported general payments places this provider in the 60th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $10,371 |
| Cilostazol | 15 | $460 |
| ClopidogrelClopidogrel Bisulfate | 13 | $167 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Hackensack
- David O'ConnorHackensack$894K
- Michael WildermanHackensack$386K
- Kristin CookHackensack$40K
- Jae Hee ChoHackensack$16K
- Steven EliasEnglewood$708K
- Joseph LombardiPomona$321K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Saum RahimiNew Brunswick$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.